| A Phase 1 Dose Escalation and Expansion Study Of SHR-1916 In Subjects With Locally Advanced Or Metastatic Solid Tumors (NCT04842630) | Jiangsu HengRui Medicine Co., Ltd. | 2021-04-08 |
| TR1801-ADC in Patients With Tumors That Express c-Met (NCT03859752) | Open Innovation Partners, Inc. | 2019-08-14 |
| RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists (NCT02112565) | City of Hope Medical Center | 2016-06-13 |
| A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors (NCT02869295) | Nektar Therapeutics | 2015-12-01 |
| Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer (NCT02293954) | City of Hope Medical Center | 2015-11-11 |
| Quantitative MRI in Assessing Disease in Patients With Brain Tumors (NCT02269111) | Vanderbilt-Ingram Cancer Center | 2015-04-01 |
| S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction (NCT02270450) | SWOG Cancer Research Network | 2015-03-09 |
| Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer (NCT02048943) | Roswell Park Cancer Institute | 2015-03-01 |
| APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery (NCT02166255) | Wake Forest University Health Sciences | 2014-12-01 |
| Palliative Care Intervention in Improving Quality of Life, Psychological Distress, and Communication in Patients With Solid Tumors Receiving Treatment (NCT01828775) | City of Hope Medical Center | 2014-09-08 |
| Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy (NCT02116530) | Alliance for Clinical Trials in Oncology | 2014-08-20 |
| Icotinib Hydrochloride in Treating Patients With Advanced Cancers (NCT02033148) | Roswell Park Cancer Institute | 2014-08-01 |
| Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors (NCT02215928) | Stanford University | 2014-07-28 |
| Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies (NCT02070406) | Jonsson Comprehensive Cancer Center | 2014-07-17 |
| Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer (NCT02194049) | University of California, Davis | 2014-07-01 |
| Placebo-Controlled Therapeutic Trial for the Prevention of Lymphedema (NCT01893879) | Stanford University | 2014-04-01 |
| PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer (NCT02088775) | Fox Chase Cancer Center | 2014-02-01 |
| Communication Training in Promoting Employment Retention Among Cancer Patients (NCT02895490) | Virginia Commonwealth University | 2014-01-01 |
| Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain Radiation Therapy (NCT01898130) | Northwestern University | 2013-11-27 |
| Measuring Biomarker Response to AMP-514 in Blood Samples From Patients With Solid Tumors Undergoing Radiotherapy (NCT02153151) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2013-11-11 |
| Nanosomal Docetaxel Lipid Suspension in Treating Patients With Advanced Solid Tumors (NCT01957995) | University of Southern California | 2013-11-08 |
| MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma (NCT01748721) | Morphotek | 2013-11-01 |
| Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection (NCT01249443) | AIDS Malignancy Consortium | 2013-11-01 |
| FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents (NCT02055586) | Case Comprehensive Cancer Center | 2013-10-22 |
| Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer (NCT01924260) | Edward Kim | 2013-08-09 |
| Auranofin and Sirolimus in Treating Patients With Advanced Solid Tumors or Recurrent Non-Small Cell Lung Cancer (NCT02126527) | Mayo Clinic | 2013-08-01 |
| Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer (NCT01923337) | University of California, Davis | 2013-08-01 |
| Quality of Life in Caregivers of Hospitalized Older Patients With Cancer (NCT01866969) | City of Hope Medical Center | 2013-06-01 |
| Copenhagen Prospective Personalized Oncology (CoPPO) (NCT02290522) | Ulrik Lassen | 2013-05-01 |
| Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By Surgery (NCT01835184) | National Cancer Institute (NCI) | 2013-05-01 |
| Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole Brain Radiation Therapy or Stereotactic Radiosurgery (NCT02277561) | Albert Einstein College of Medicine | 2013-04-01 |
| 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy (NCT01806675) | Sanjiv Sam Gambhir | 2013-03-04 |
| A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors (NCT01764087) | Hanmi Pharmaceutical Company Limited | 2012-12-01 |
| Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors (NCT01713972) | Manisha Shah | 2012-11-19 |
| Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors (NCT01217450) | National Cancer Institute (NCI) | 2012-10-01 |
| Hypofractionated Stereotactic Radiosurgery in Treating Patients With Large Brain Metastasis (NCT01705548) | Emory University | 2012-09-24 |
| Recombinant Albumin Fusion Protein sEphB4-HSA in Treating Patients With Metastatic or Recurrent Solid Tumors (NCT01642342) | University of Southern California | 2012-09-06 |
| Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies (NCT01705106) | University of Chicago | 2012-08-29 |
| A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors (NCT01631279) | Proacta, Incorporated | 2012-08-01 |
| Palliative Care Intervention in Patients With Solid Tumors Participating in Phase I Clinical Trials (NCT01612598) | City of Hope Medical Center | 2012-07-01 |
| Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery (NCT01791088) | University of Chicago | 2012-06-13 |
| Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers (NCT01560325) | Chong Kun Dang Pharmaceutical | 2012-06-01 |
| PI3K Inhibitor BKM120 and Docetaxel in Treating Patients With Advanced Solid Tumor That is Locally Advanced, Cannot Be Removed By Surgery, or Metastatic (NCT01540253) | Roswell Park Cancer Institute | 2012-05-01 |
| Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors (NCT01573780) | Roswell Park Cancer Institute | 2012-04-01 |
| Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers (NCT01497392) | Roswell Park Cancer Institute | 2012-03-29 |
| Positron Emission Tomography/Magnetic Resonance Imaging in Patients (NCT01557881) | Case Comprehensive Cancer Center | 2012-02-01 |
| Entolimod in Treating Patients With Locally Advanced or Metastatic Solid Tumors That Cannot Be Removed By Surgery (NCT01527136) | Roswell Park Cancer Institute | 2012-01-01 |
| 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Recurrent Tumors (NCT01470365) | Fox Chase Cancer Center | 2011-11-03 |
| An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVEN in Subjects With Cancer Who Also Have Impaired Renal Function (NCT01418677) | Eisai Inc. | 2011-10-01 |
| Cognitive Assessments in Patients With Cancer Undergoing Chemotherapy (NCT01506440) | Wake Forest University Health Sciences | 2011-10-01 |
| Hsp90 Inhibitor AUY922 in Treating Older Patients With Advanced Solid Malignancies (NCT01602627) | Dale Shepard, MD, PhD | 2011-09-01 |
| Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases (NCT01417403) | Virginia Commonwealth University | 2011-08-01 |
| ABC294640 in Treating Patients With Advanced Solid Tumors (NCT01488513) | RedHill Biopharma Limited | 2011-08-01 |
| Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients (NCT01337765) | Pfizer | 2011-07-08 |
| Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery (NCT01372774) | Alliance for Clinical Trials in Oncology | 2011-07-01 |
| Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer (NCT01383668) | Mayo Clinic | 2011-06-01 |
| Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy (NCT01198145) | Alliance for Clinical Trials in Oncology | 2011-04-01 |
| NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors (NCT01324115) | Cancer Research UK | 2011-04-01 |
| Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases (NCT01227954) | Radiation Therapy Oncology Group | 2011-03-01 |
| Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors (NCT01234922) | Wake Forest University Health Sciences | 2011-02-01 |
| Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT) (NCT01032278) | M.D. Anderson Cancer Center | 2011-01-25 |
| Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer (NCT01245205) | National Cancer Institute (NCI) | 2010-11-01 |
| Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors (NCT01233505) | National Cancer Institute (NCI) | 2010-10-01 |
| Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies (NCT01243359) | National Cancer Institute (NCI) | 2010-10-01 |
| Ridaforolimus and Vorinostat in Treating Patients With Advanced Solid Tumors or Lymphoma (NCT01169532) | Fox Chase Cancer Center | 2010-10-01 |
| Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors (NCT01407562) | Rutgers, The State University of New Jersey | 2010-09-17 |
| Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors (NCT01206465) | University of Nebraska | 2010-09-14 |
| 1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid Tumors (NCT01191216) | National Cancer Institute (NCI) | 2010-09-01 |
| Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors (NCT01198184) | National Cancer Institute (NCI) | 2010-08-01 |
| Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain (NCT00930332) | NCIC Clinical Trials Group | 2010-06-17 |
| Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia (NCT01159301) | National Cancer Institute (NCI) | 2010-06-01 |
| RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors (NCT01158274) | National Cancer Institute (NCI) | 2010-06-01 |
| Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor (NCT01096381) | Vanderbilt-Ingram Cancer Center | 2010-03-01 |
| S0916, MLN1202 in Treating Patients With Bone Metastases (NCT01015560) | SWOG Cancer Research Network | 2010-03-01 |
| Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors (NCT01118611) | Cancer Research UK | 2010-03-01 |
| Gamma-Secretase Inhibitor RO4929097 in Treating Patients With Metastatic or Unresectable Solid Malignancies (NCT01096355) | National Cancer Institute (NCI) | 2010-02-01 |
| Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer (NCT01042535) | H. Lee Moffitt Cancer Center and Research Institute | 2009-12-28 |
| Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers (NCT01028859) | Chong Kun Dang Pharmaceutical | 2009-12-01 |
| Fentanyl Sublingual Spray in Treating Opioid-tolerant Cancer Patients With or Without Oral Mucositis (NCT00956254) | INSYS Therapeutics Inc | 2009-10-01 |
| Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors (NCT01098643) | Vanderbilt University | 2009-10-01 |
| Screening Tools to Predict Treatment Outcome in Older Cancer Patients Who Are Undergoing Treatment (NCT01005693) | Ziekenhuis Netwerk Antwerpen (ZNA) | 2009-10-01 |
| Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen Therapy (NCT00956813) | Alliance for Clinical Trials in Oncology | 2009-10-01 |
| Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors (NCT00878904) | University of California, San Francisco | 2009-09-13 |
| 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer (NCT00935090) | Barbara Ann Karmanos Cancer Institute | 2009-09-01 |
| Registry of Older Patients With Cancer (NCT01137825) | UNC Lineberger Comprehensive Cancer Center | 2009-09-01 |
| Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants (NCT00992303) | University of Texas Southwestern Medical Center | 2009-09-01 |
| Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy (NCT00949949) | Mayo Clinic | 2009-09-01 |
| Exercise in Lessening Fatigue Caused by Cancer in Patients Undergoing Chemotherapy (NCT00924651) | Gary Morrow | 2009-09-01 |
| Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy (NCT00890747) | National Cancer Institute (NCI) | 2009-08-01 |
| Lapatinib and Ixabepilone in Treating Patients With Advanced Solid Tumors (NCT00804310) | University of California, Davis | 2009-08-01 |
| Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride (NCT00981162) | Roswell Park Cancer Institute | 2009-08-01 |
| SORAVE - Sorafenib and Everolimus in Solid Tumors (NCT00933777) | University of Cologne | 2009-07-01 |
| FAU in Treating Patients With Advanced Solid Tumors or Lymphoma (NCT00769288) | National Cancer Institute (NCI) | 2009-07-01 |
| White Wine or Nutritional Supplement in Improving Appetite in Patients With Cancer (NCT00936728) | Academic and Community Cancer Research United | 2009-07-01 |
| Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors. (NCT00849550) | Herbert Hurwitz | 2009-07-01 |
| Magnesium Oxide in Treating Hot Flashes in Menopausal Women With Cancer (NCT01008904) | Virginia Commonwealth University | 2009-07-01 |
| Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery (NCT00891072) | National Cancer Institute (NCI) | 2009-07-01 |
| Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy (NCT00952848) | Virginia Commonwealth University | 2009-06-12 |
| Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy (NCT01019187) | Abramson Cancer Center at Penn Medicine | 2009-06-01 |
| Lung Function Testing in Patients With Locally Advanced or Metastatic Solid Tumors (NCT00914147) | Barbara Ann Karmanos Cancer Institute | 2009-05-01 |